The investment seeks high current income... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category LongShort
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FIJYX | 41.15 | N/A | N/A |
| Fidelity Advisor Biotechnology Z | |||
| AAIPX | 19.50 | -0.10 | -0.51% |
| American Beacon International Eq Inv | |||
| GEMQX | 14.74 | -0.22 | -1.47% |
| Goldman Sachs Emerging Mkts Eq ex. Chn R | |||
| TVOIX | 40.72 | -0.70 | -1.69% |
| Touchstone Small Cap Value Institutional | |||
| ASLGX | 145.38 | -3.23 | -2.17% |
| American Century Select R5 | |||
A.I.dvisor tells us that CBHMX and CBHCX have been poorly correlated (+17% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CBHMX and CBHCX's prices will move in lockstep.
| Ticker / NAME | Correlation To CBHMX | 1D Price Change % | ||
|---|---|---|---|---|
| CBHMX | 100% | +0.58% | ||
| CBHCX - CBHMX | 17% Poorly correlated | +0.59% | ||
| SMNIX - CBHMX | 16% Poorly correlated | +1.26% | ||
| SMNAX - CBHMX | 16% Poorly correlated | +1.26% | ||
| CBHAX - CBHMX | 16% Poorly correlated | +0.70% | ||
| CBHIX - CBHMX | 14% Poorly correlated | +0.69% | ||
More | ||||